A

Ansun Biopharma, Inc.

27 employees

Ansun BioPharma is a clinical-stage biopharmaceutical company focused on the development of host-directed anti-viral.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Medical
Biopharma
Clinical Trials

Date founded

2003

Funding rounds raised

Total raised

$100M

from 12 investors over 12 rounds

A

Ansun Biopharma, Inc. raised $100M on October 15, 2019

Investors: Lilly Asia Ventures, 经纬创投（北京）投资管理顾问有限公司, Korea Investment Partners, Oceanpine Capital and 3E Bioventures Capital

A

Ansun Biopharma, Inc. raised $85M on May 14, 2018

Investors: 经纬创投（北京）投资管理顾问有限公司, Lilly Asia Ventures, LYFE Capital, Sinopharm Capital 国药资本, Yuanming Capital, Oceanpine Capital and 3E Bioventures Capital

FAQ